It is game-changing in terms of establishing this new class of medications, which are designer drugs for hypertrophic cardiomyopathy, in the treatment armamentarium of physicians.
These drugs specifically target the contractility of the heart by reducing the interaction between actin and myosin within cardiac muscle cells.
#hypertrophic-cardiomyopathy #cardiac-myosin-inhibitor #clinical-trial #treatment-options #medication-development
[
Collection
]
[
|
...
]